An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease
Recruiting · NCT06754280 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Illinois at Chicago
View the official record on ClinicalTrials.gov →Interventions studied
Attention ControlRESET-CKD
What this trial is about
RESET-CKD is evaluating an intervention to support Black adults with chronic kidney disease (CKD) to reduce their sedentary (e.g., sitting) time. Half of the participants will be randomized to the intervention, where the goal is to support individuals to reduce their sitting time, and the other half will be randomized to an attention control condition that provides CKD-related education not related to sedentary behavior. All participants will be followed for 12 weeks.
Who can take part
Age range
35 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Self-identifies as Black or African American
- Age ≥35 to ≤80 years old
- CKD Stage 1-4
- Self-reported 6 or more hours/day of sedentary time
- Ability to speak/read/understand English
- Has access to a telephone
Exclusion criteria
- Being unable to walk 1 block
- Being unable to stand from a seated position without assistance
- Using a wheelchair, walker, or cane for all of their ambulation
- Presence of a condition(s) or diagnosis, either physical or psychological, that precludes participation, including: Lower-extremity amputation (AKA or BKA) without prosthetic, Orthopedic condition that would preclude prompted sit-to-stand transitions or standing, Neurologic or psychiatric condition that would preclude prompted sit-to- stand transitions or standing, Severe cognitive impairment, Unstable coronary artery disease (i.e., angina with activity), Orthostatic hypotension
- Kidney transplant
- Any other condition that the investigator considers precludes participation in the trial
- Participated in the Patient Advisory Board
Where it is running
1 location listed across 1 US state.
- UI Health/University of Illinois Chicago - Chicago, Illinois, United States